Skip to main content
Top
Published in: Surgical Endoscopy 7/2018

01-07-2018

Adenoma detection rate metrics in colorectal cancer surveillance colonoscopy

Authors: Jamie M. Tjaden, Jessica A. Hause, Daniel Berger, Samantha K. Duveneck, Shriram M. Jakate, Bruce A. Orkin, Elizabeth L. Hubbard, Joshua E. Melson

Published in: Surgical Endoscopy | Issue 7/2018

Login to get access

Abstract

Background

A target goal for screening adenoma detection rate (S-ADR) of ≥ 25% has been set to define high-quality colonoscopy performance. However, there is no current accepted target goal for ADR in colorectal cancer (CRC) surveillance. This makes quality assessment challenging when physicians perform cancer surveillance colonoscopy but minimal screening procedures.

Methods

In this cohort study, consecutive colonoscopies performed at either Rush University Medical Center or Rush Oak Park Hospital by a gastroenterologist or colorectal surgeon in average risk screening population and CRC surveillance population were reviewed retrospectively from 2006 to 2012 and prospectively from 2013 to 2016. ADR in first surveillance colonoscopy following surgical resection of CRC (CRC-ADR) was reported in high-quality detectors (HQD) or low-quality detectors (LQD) based on achievement of 25% ADR in consecutive screening colonoscopy in average risk patients. Pearson’s correlation was used to describe the association between individual S-ADR and CRC-ADR for colonoscopists.

Results

There was a very strong positive correlation (r = 0.88, p = 0.002) between ADR in average risk screening and first time CRC surveillance. For HQD as defined by S-ADR ≥ 25% (n = 10 colonoscopists), the CRC-ADR was 37.7% (78/207, SD 8%) which was very similar to their respective S-ADR of 33.4% (816/2440, p = 0.22). For LQD (n = 5 colonoscopists), the CRC-ADR was 20.2% (40/198) which was similar to their respective S-ADR of 20.1% (119/591, p = 0.99). The CRC-ADR was significantly higher for HQD than for LQD (37.7 vs. 20.2%, p < 0.0001).

Conclusions

The major finding of this study is a defined CRC-ADR for HQD based on the ability to achieve S-ADR ≥ 25%. S-ADR strongly correlates with CRC-ADR. CRC-ADR is quite similar to the colonoscopists’ respective S-ADR for both HQD and LQD. For colonoscopists who perform limited screening colonoscopies but do perform CRC surveillance colonoscopies, ADR metrics similar to S-ADR to assess quality in colonoscopy could be considered.
Literature
1.
go back to reference Rex DK, Schoenfeld PS, Cohen J, Pike IM, Febberty MB, Lieb JG, Park WG, Rizk MK, Sawhney MS, Shaheen NJ, Wani S, Weinberg DS (2015) Quality indicators for colonoscopy. Gastrointest Endosc 81:31–53CrossRefPubMed Rex DK, Schoenfeld PS, Cohen J, Pike IM, Febberty MB, Lieb JG, Park WG, Rizk MK, Sawhney MS, Shaheen NJ, Wani S, Weinberg DS (2015) Quality indicators for colonoscopy. Gastrointest Endosc 81:31–53CrossRefPubMed
2.
go back to reference Kaminski MF, Regula J, Kraszewska E, Polkowski M, Wojciechowska U, Didkowska J, Zwierko M, Rupinski M, Noawacki MP, Butruk E (2010) Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 362:1795–1803CrossRefPubMed Kaminski MF, Regula J, Kraszewska E, Polkowski M, Wojciechowska U, Didkowska J, Zwierko M, Rupinski M, Noawacki MP, Butruk E (2010) Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 362:1795–1803CrossRefPubMed
3.
go back to reference Corley DA, Jensen CD, Marks AR, Zhao WK, Lee JK, Doubeni CA, Zauber AG, De Boer J, Fireman BH, Schottinger JE, Quinn VP, Ghai NR, Levin TR, Quesenberry CP. (2014) Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med 370:1298 – 306CrossRefPubMedPubMedCentral Corley DA, Jensen CD, Marks AR, Zhao WK, Lee JK, Doubeni CA, Zauber AG, De Boer J, Fireman BH, Schottinger JE, Quinn VP, Ghai NR, Levin TR, Quesenberry CP. (2014) Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med 370:1298 – 306CrossRefPubMedPubMedCentral
4.
go back to reference Fuccio L, Spada C, Frazzoni L, Paggi S, Vitale G, Laterza L, Mussetto A, Rojas F, Radaelli F, Hassan C, Petruzziello L, Frazzoni M (2015) Higher adenoma recurrence rate after left- versus right-sided colectomy for colon cancer. Gastrointest Endosc 82:337–343CrossRefPubMed Fuccio L, Spada C, Frazzoni L, Paggi S, Vitale G, Laterza L, Mussetto A, Rojas F, Radaelli F, Hassan C, Petruzziello L, Frazzoni M (2015) Higher adenoma recurrence rate after left- versus right-sided colectomy for colon cancer. Gastrointest Endosc 82:337–343CrossRefPubMed
5.
go back to reference Kahi CJ, Vemulapalli KC, Johnson CS, Rex DK (2014) Improving measurement of the adenoma detection rate and adenoma per colonoscopy quality metric: the Indiana University experience. Gastrointest Endosc 79:448–454CrossRefPubMed Kahi CJ, Vemulapalli KC, Johnson CS, Rex DK (2014) Improving measurement of the adenoma detection rate and adenoma per colonoscopy quality metric: the Indiana University experience. Gastrointest Endosc 79:448–454CrossRefPubMed
6.
go back to reference Tierney J, Bauconi RB, Holzman MD, Poulose BK, Pierce RA (2016) Current trends in the practice of endoscopy among surgeons in the USA. Surg Endosc 31:1675–1679CrossRefPubMed Tierney J, Bauconi RB, Holzman MD, Poulose BK, Pierce RA (2016) Current trends in the practice of endoscopy among surgeons in the USA. Surg Endosc 31:1675–1679CrossRefPubMed
7.
go back to reference Wexner SD, Garbus JE, Singh JJ (2001) SAGES Colonoscopy Outcomes Group. A prospective analysis of 13,580 colonoscopies. Reevaluation of credentialing guidelines. Surg Endosc 15:251–261CrossRefPubMed Wexner SD, Garbus JE, Singh JJ (2001) SAGES Colonoscopy Outcomes Group. A prospective analysis of 13,580 colonoscopies. Reevaluation of credentialing guidelines. Surg Endosc 15:251–261CrossRefPubMed
8.
go back to reference Bond JH (2000) Polyp guideline: diagnosis, treatment, and surveillance for patients with colorectal polyps. Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 95:3053–3063CrossRefPubMed Bond JH (2000) Polyp guideline: diagnosis, treatment, and surveillance for patients with colorectal polyps. Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 95:3053–3063CrossRefPubMed
9.
go back to reference Greenspan M, Rajan KB, Baig A, Beck T, Mobarhan S, Melson J (2013) Advanced adenoma detection rate is independent of nonadvanced adenoma detection rate. Am J Gastroenterol 108:1286–1292CrossRefPubMed Greenspan M, Rajan KB, Baig A, Beck T, Mobarhan S, Melson J (2013) Advanced adenoma detection rate is independent of nonadvanced adenoma detection rate. Am J Gastroenterol 108:1286–1292CrossRefPubMed
10.
go back to reference Chen SC, Rex DK (2007) Endoscopist can be more powerful than age and male gender in predicting adenoma detection at colonoscopy. Am J Gastroenterol 102:856–861CrossRefPubMed Chen SC, Rex DK (2007) Endoscopist can be more powerful than age and male gender in predicting adenoma detection at colonoscopy. Am J Gastroenterol 102:856–861CrossRefPubMed
11.
go back to reference Rex DK, Lehman GA, Ulbright TM, Smith JJ, Pound DC, Hawes RH, Helper DJ, Wiersema MJ, Langefeld CD, Li W (1993) Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender, and family history. Am J Gastroenterol 88:825–831PubMed Rex DK, Lehman GA, Ulbright TM, Smith JJ, Pound DC, Hawes RH, Helper DJ, Wiersema MJ, Langefeld CD, Li W (1993) Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender, and family history. Am J Gastroenterol 88:825–831PubMed
12.
go back to reference Anderson JC, Butterly L, Goodrich M, Robinson CM, Weiss JE (2013) Differences in detection rates of adenomas and serrated polyps in screening versus surveillance colonoscopies, based on the New Hampshire colonoscopy registry. Clin Gastroenterol Hepatol 11:1308–1312CrossRefPubMed Anderson JC, Butterly L, Goodrich M, Robinson CM, Weiss JE (2013) Differences in detection rates of adenomas and serrated polyps in screening versus surveillance colonoscopies, based on the New Hampshire colonoscopy registry. Clin Gastroenterol Hepatol 11:1308–1312CrossRefPubMed
13.
go back to reference Corley DA, Jensen CD, Marks AR, Wei ZK, De Boer J, Levin TR, Doubeni C, Fireman BH, Quesenberry CP (2013) Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs. Clin Gastroenterol Hepatol 11:172–180CrossRefPubMed Corley DA, Jensen CD, Marks AR, Wei ZK, De Boer J, Levin TR, Doubeni C, Fireman BH, Quesenberry CP (2013) Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs. Clin Gastroenterol Hepatol 11:172–180CrossRefPubMed
14.
go back to reference Aghdaei HA, Mojarad NM, Ashtari S, Pourhoseingholi MA, Chaleshi V, Anaraki F, Haghazali M, Zali MR (2017) Polyp detection and pathological features in patients undergoing a comprehensive colonoscopy screening. World J Gastrointest Pathophysiol 15:3–10CrossRef Aghdaei HA, Mojarad NM, Ashtari S, Pourhoseingholi MA, Chaleshi V, Anaraki F, Haghazali M, Zali MR (2017) Polyp detection and pathological features in patients undergoing a comprehensive colonoscopy screening. World J Gastrointest Pathophysiol 15:3–10CrossRef
15.
go back to reference Ferlitsch M, Reinhart K, Pramhas S, Wiener C, Gal O, Bannert C, Hassler M, Kozbial K, Dunkler D, Trauner M, Weiss W (2011) Sex-specific prevalence of adenomas, advanced adenomas, and colorectal cancer in individuals undergoing screening colonoscopy. JAMA 306:1352–1358CrossRefPubMed Ferlitsch M, Reinhart K, Pramhas S, Wiener C, Gal O, Bannert C, Hassler M, Kozbial K, Dunkler D, Trauner M, Weiss W (2011) Sex-specific prevalence of adenomas, advanced adenomas, and colorectal cancer in individuals undergoing screening colonoscopy. JAMA 306:1352–1358CrossRefPubMed
16.
go back to reference Waldmann E, Heinze G, Ferlitsh A, Gessl I, Sallinger D, Jeschek P, Britt-Arias M, Salzl P, Fasching E, Jilma B, Kundi M, Trauner M, Ferlitsch M (2016) Risk factors cannot explain the higher prevalence rates of precancerous colorectal lesions in men. Br J Cancer 115:1421–1429CrossRefPubMedPubMedCentral Waldmann E, Heinze G, Ferlitsh A, Gessl I, Sallinger D, Jeschek P, Britt-Arias M, Salzl P, Fasching E, Jilma B, Kundi M, Trauner M, Ferlitsch M (2016) Risk factors cannot explain the higher prevalence rates of precancerous colorectal lesions in men. Br J Cancer 115:1421–1429CrossRefPubMedPubMedCentral
17.
go back to reference Clark B, Protiva P, Nagar A, Imaeda A, Ciarleglio M, Deng Y, Laine L (2016) Quantification of adequate bowel preparation for screening or surveillance colonscopy in men. Gastroenterology 150:396–405CrossRefPubMed Clark B, Protiva P, Nagar A, Imaeda A, Ciarleglio M, Deng Y, Laine L (2016) Quantification of adequate bowel preparation for screening or surveillance colonscopy in men. Gastroenterology 150:396–405CrossRefPubMed
18.
go back to reference Barclay RL, Vari JJ, Greenlaw RL (2008) Effect of a time-dependent colonoscopic withdrawal protocol on adenoma detection during screening colonoscopy. Clin Gastroenterol Hepatol 6:1091–1098CrossRefPubMed Barclay RL, Vari JJ, Greenlaw RL (2008) Effect of a time-dependent colonoscopic withdrawal protocol on adenoma detection during screening colonoscopy. Clin Gastroenterol Hepatol 6:1091–1098CrossRefPubMed
20.
go back to reference Yamazaki T, Takii Y, Okamoto H, Sakai Y, Hatakeyama K (1997) What is the risk factor for metachronous colorectal carcinoma? Dis Colon Rectum 40:935–938CrossRefPubMed Yamazaki T, Takii Y, Okamoto H, Sakai Y, Hatakeyama K (1997) What is the risk factor for metachronous colorectal carcinoma? Dis Colon Rectum 40:935–938CrossRefPubMed
21.
go back to reference Hilsden RJ, Bridges R, Dube C, McGregor ES, Naugler C, Rose SM, Rostom A, Heitman SJ (2016) Defining benchmarks for adenoma detection rate and adenomas per colonoscopy in patients undergoing colonoscopy due to a positive fecal immunochemical test. Am J Gastroenterol 111:1743–1749CrossRefPubMed Hilsden RJ, Bridges R, Dube C, McGregor ES, Naugler C, Rose SM, Rostom A, Heitman SJ (2016) Defining benchmarks for adenoma detection rate and adenomas per colonoscopy in patients undergoing colonoscopy due to a positive fecal immunochemical test. Am J Gastroenterol 111:1743–1749CrossRefPubMed
Metadata
Title
Adenoma detection rate metrics in colorectal cancer surveillance colonoscopy
Authors
Jamie M. Tjaden
Jessica A. Hause
Daniel Berger
Samantha K. Duveneck
Shriram M. Jakate
Bruce A. Orkin
Elizabeth L. Hubbard
Joshua E. Melson
Publication date
01-07-2018
Publisher
Springer US
Published in
Surgical Endoscopy / Issue 7/2018
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-018-6025-3

Other articles of this Issue 7/2018

Surgical Endoscopy 7/2018 Go to the issue